Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
September 28 2023 - 9:02AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2023
Commission File Number: 001-41411
Haleon plc
(Translation
of registrant’s name into English)
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F:
EXHIBIT INDEX
Exhibit
Number
|
Description
|
99.1
|
28
September 2023 - Director Declaration
|
99.1
Haleon plc: Director Declaration
28 September 2023: In accordance with paragraph
9.6.14R of the Listing Rules of the UK Financial Conduct Authority,
Haleon plc (the "Company") (LSE/NYSE: HLN) notes that Deirdre
Mahlan, an Independent Non-Executive Director and Chair of the
Audit & Risk Committee of the Company has been
appointed Interim
President, Chief Executive
Officer and Chairperson of the Board of The Duckhorn Portfolio,
Inc. (NYSE: NAPA) with immediate effect from 27 September
2023.
There is no further information to be disclosed in respect of
paragraph 9.6.14.
Amanda Mellor
Company
Secretary
About Haleon
Haleon (LSE / NYSE: HLN) is a global leader in consumer health,
with a purpose to deliver better everyday health with humanity.
Haleon's product portfolio spans five major categories - Oral
Health, Pain Relief, Respiratory Health, Digestive Health and
Other, and Vitamins, Minerals and Supplements (VMS). Its
long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren,
Theraflu, Otrivin, Polident, parodontax and Centrum - are built on
trusted science, innovation and deep human
understanding.
For more information, please visit
www.haleon.com.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
HALEON PLC
(Registrant)
|
Date:
September 28, 2023
|
By:
|
/s/
Amanda Mellor
|
|
|
Name:
|
Amanda
Mellor
|
|
|
Title:
|
Company
Secretary
|
Haleon (NYSE:HLN)
Historical Stock Chart
From Jan 2025 to Feb 2025
Haleon (NYSE:HLN)
Historical Stock Chart
From Feb 2024 to Feb 2025